Search results
Pfizer announces another $1.5B in cost cuts — and plans for more to come
Endpoints News· 3 days agoMonths after beginning a $4 billion savings strategy, Pfizer is planning on a new $1.5 billion round...
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 2 days agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 3 days agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
Invest $50k In This Stock To Become A Dividend Millionaire In 10 Years
Benzinga via Yahoo Finance· 1 day agoWarren Buffett, the most successful dividend investor of all time, owes his success to a simple yet...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 3 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 6 days agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
Pfizer targets $1.5 billion in savings by 2027 as it streamlines operations
WSAU Wausau· 3 days ago(Reuters) -U.S. drugmaker Pfizer said on Wednesday it had launched a multi-year program to reduce...
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 5 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
1 Top Dividend Stock to Load Up On Now
Motley Fool via Yahoo Finance· 4 days agoThey are the bedrock of a portfolio designed for the long haul, offering a balance of stability and growth potential. One healthcare giant stands out In...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks via Yahoo Finance· 3 days agoFrom a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a...